Human insulin analogue and acylated derivative thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9458219
APP PUB NO 20140329745A1
SERIAL NO

14363328

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a human insulin analog, an acylated derivative thereof and a physiologically acceptable salt. The present invention further provides a preparation method for the insulin analog and an application of the insulin analog as a therapeutic agent, and particularly as a diabetes mellitus therapeutic agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHANGHAI HENGRUI PHARMACEUTICAL CO LTDNO 279 WENJING ROAD MINHANG DISTRICT SHANGHAI 200245
JIANGSU HENGRUI MEDICINE CO LTD222047 NO 7 KUNLUN MOUNTAIN ROAD LIANYUNGANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE JIANGSU LIANYUNGANG CITY JIANGSU PROVINCE 222047

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fang, Chunqian Shanghai, CN 1 1
Liu, Jiajian Shanghai, CN 21 255
Sun, Changan Shanghai, CN 8 79
Sun, Piaoyang Lianyungang, CN 52 122
Wang, Yali Shanghai, CN 91 198
Yuan, Hengli Shanghai, CN 5 4
Yuan, Jijun Shanghai, CN 13 131
Zhang, Lianshan Lianyungang, CN 78 687

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00